Nuchev Ltd (ASX: NUC) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Nuchev Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Nuchev Ltd (ASX: NUC)
Latest News
Share Gainers
Why Iron Road, Nuchev, Telix, & Treasury Wine shares are pushing higher today
⏸️ Shares to Watch
Should you buy these 2 ASX dairy shares instead of A2 Milk?
Growth Shares
A2 Milk and 1 other top ASX growth share to buy this month
ASX Share Market News
3 quarterly updates you might have missed: Champion Iron, Life360, & Nuchev
ASX Share Market News
Why I'd buy and hold a2 Milk shares until 2025
ASX Share Market News
Is the a2 Milk share price too high to buy?
ASX Share Market News
Fund managers have been buying these ASX shares this week
ASX Share Market News
This ASX infant formula share just reported explosive growth. Could it be the next a2 Milk?
ASX Share Market News
2 ASX 200 companies playing a vital role in the coronavirus crisis
ASX Share Market News
3 ASX shares to buy with $3,000
ASX Share Market News
3 top ASX growth shares to diversify your portfolio
ASX Share Market News
3 ASX growth shares to buy and hold beyond 2025
NUC ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Nuchev Ltd
Nuchev Ltd. produces and sells goat milk based formula and nutrition products. It offers Oli6 Goat Milk for infant, follow-on, toddler, and junior drink formula. The company was founded by Ben Dingle in 2013 and is headquartered in Melbourne, Australia.
NUC Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 12 Oct 2026 | $0.08 | $-0.01 | -11.76% | 2,814 | $0.08 | $0.08 | $0.08 |
| 17 Sep 2026 | $0.09 | $0.00 | 0.00% | 22,986 | $0.09 | $0.09 | $0.09 |
| 16 Sep 2026 | $0.09 | $0.00 | 0.00% | 1,087 | $0.09 | $0.09 | $0.09 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 22 Jan 2026 | Ben Dingle | Issued | 479,102 | $64,678 |
Conversion of securities. Non-cash consideration: Share Rights issued under the Equity Incentive Plan, in lieu of payment of Directors fees of $61,325.00.
|
| 22 Jan 2026 | Ben Dingle | Exercise | 479,102 | $64,678 |
Conversion of securities. 354,210 Share Rights, Non-cash consideration: Share Rights issued under the Equity Incentive Plan, in lieu of payment of Directors fees of $61,325.00.
|
| 22 Jan 2026 | Elizabeth Smith (Liz) | Exercise | 278,750 | $37,631 |
Conversion of securities. Non-cash consideration: Share Rights issued under the Equity Incentive Plan, in lieu of payment of Directors fees of $35,680.00. 212,267 Rights
|
| 22 Jan 2026 | Elizabeth Smith (Liz) | Issued | 278,750 | $37,631 |
Conversion of securities. Non-cash consideration: Share Rights issued under the Equity Incentive Plan, in lieu of payment of Directors fees of $35,680.00.
|
| 22 Jan 2026 | Craig Silbery | Exercise | 474,746 | $64,090 |
Conversion of securities. Non-cash consideration: Share Rights issued under the Equity Incentive Plan, in lieu of payment of Directors fees of $60,768.00. 350,990 Share Rights
|
| 22 Jan 2026 | Craig Silbery | Issued | 474,746 | $64,090 |
Conversion of securities. As per announcement on 22/01/2026
|
| 04 Dec 2025 | Meng (Leo) Zhang | Issued | 385,454 | $67,033 |
Director remuneration. Unquoted Share Rights 385,454
|
| 31 Oct 2025 | Ben Dingle | Issued | 354,210 | $61,600 |
Director remuneration. Unquoted Share Rights 833,312
|
| 31 Oct 2025 | Craig Silbery | Issued | 350,990 | $61,040 |
Director remuneration. Unquoted Share Rights 825,736
|
| 31 Oct 2025 | Elizabeth Smith (Liz) | Issued | 212,267 | $36,915 |
Director remuneration. Unquoted Share Rights 491,017
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Ben McFarlane Dingle | Non-Executive ChairmanNon-Executive Director | Oct 2023 |
Mr Dingle brings experience from the dairy nutrition sector as co founder of New Zealand's Synlait Group, which was established in 1999. Ben was in guiding the IPO of Synlait Milk in 2013. Ben was also responsible for the construction and management of a portfolio of dairy operations on the Canterbury Plains that totalled approximately 15,000 cows. His role included establishment and implementation of irrigation schemes, and adoption of world farming practices. He is the member of the People and Culture Committee and Risk Committee.
|
| Ms Elizabeth Smith (Liz) | Non-Executive Director | Jul 2024 |
Ms Smith has skills in finance and accounting, strategy, M&A, risk and governance and experience advising businesses. Liz has worked across a range of industries (including food and fast-moving consumer goods) and for businesses ranging from small privately owned companies to large ASX listed entities. She is the chairperson of the risk committee and member of the People and Culture Committee.
|
| Mr Craig Silbery | Non-Executive Director | Oct 2023 |
Mr Silbery is an entrepreneur who established and led Life-Space Group from start up to an exit with the sale to Guangzhou based By-Health in 2018. Craig built Life-Space around a core foundation of probiotic formulas for infants and pregnant women based on Human Microbiome science.
|
| Mr Meng (Leo) Zhang | Non-Executive Director | May 2025 |
Mr Zhang is a business leader and entrepreneur with over 10 years of cross border experience in brand management, international trade, and corporate governance. Leo joined H&S Group as a partner in 2020 and currently serves as a Director of the Group as well as CEO of the H&S Global Brand Center (GBC), a portfolio of owned and strategic partner brands. Leo brings to the Board knowledge of the Asia-Pacific consumer goods market, financial acumen, and strategic insight into growth brand development.
|
| Ms Tamara Barr | Company Secretary | Feb 2022 |
-
|
| Matthew Parker | CFO |
-
|
|
| Tamara Barr | Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| H&S Global Holdings Pty Ltd <H&S Investment Unit A/C>-i | 44,382,133 | 28.30% |
| 402339 Pty Ltd <The Whiti A/C> | 37,853,680 | 24.14% |
| Brauer Natural Medicine Pty Ltd | 22,435,898 | 14.31% |
| HSBC Custody Nominees (Australia) Limited | 12,810,713 | 8.17% |
| H&S Global Holdings Pty Ltd <H&S Investment Unit A/C>-ii | 8,749,000 | 5.58% |
| Mr Craig Silbery-i | 5,035,370 | 3.21% |
| Mr Craig Silbery <Silbery Super Fund A/C> | 2,271,561 | 1.45% |
| Gigo Investment Pty Ltd <Gigo A/C> | 1,374,949 | 0.88% |
| Cw Investment Holdings Pty Ltd <Cw Investment Holdings A/C> | 1,030,000 | 0.66% |
| H&S Global Holdings Pty Ltd | 1,024,732 | 0.65% |
| Kirwood Capital Direct Investments 1 Pty Ltd <Kirwood Cap Direct Invest 1> | 1,000,000 | 0.64% |
| Finclear Services Pty Ltd <Superhero Securities A/C> | 970,811 | 0.62% |
| Cg Nominees (Australia) Pty Ltd | 900,000 | 0.57% |
| Top End Enterprises Pty Ltd <Atkins Family A/C> | 892,644 | 0.57% |
| Ataturk Investments Pty Ltd | 774,289 | 0.49% |
| Bk Custodian Pty Ltd <Earle/Blackwell Family A/C> | 605,364 | 0.39% |
| Mr Richard Lea Allnutt | 479,442 | 0.31% |
| Ben Mcfarlane Dingle | 479,102 | 0.31% |
| Mr Craig Silbery-ii | 474,746 | 0.30% |
| Daho Pty Ltd <The Dhb S/F A/C> | 450,000 | 0.29% |